You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Australia Patent: 2009282986


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2009282986

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 13, 2029 Vero Biotech Inc GENOSYL nitric oxide
⤷  Get Started Free Jul 14, 2030 Vero Biotech Inc GENOSYL nitric oxide
⤷  Get Started Free Aug 13, 2029 Vero Biotech Inc GENOSYL nitric oxide
⤷  Get Started Free Aug 13, 2029 Vero Biotech Inc GENOSYL nitric oxide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Australia Patent AU2009282986

Last updated: August 8, 2025

Introduction

Patent AU2009282986 pertains to a pharmaceutical invention filed in Australia. As a key intellectual property asset, understanding its scope, claims, and position within the patent landscape is critical for stakeholders involved in drug development, commercialization, or licensing. This analysis provides a comprehensive overview of the patent’s claims, their legal scope, and the broader patent environment surrounding it.

Patent Overview

Patent AU2009282986 was filed by [Assignee/Applicant, if available], and published on [Publication date], with the Patent Office in Australia. This patent is classified under therapeutic or pharmaceutical inventions, likely falling within Class A61K, which covers medicinal preparations.

Key aspects:

  • Filed Date: [Insert date, e.g., 2009-10-16]
  • Priority Date: [If applicable]
  • Patent Term expiry: 20 years from filing, subject to adjustments
  • Application Status: [Specify whether granted, pending, or abandoned]

Scope and Claims Analysis

Claims Structure and Types

The claims define the extent of legal protection conferred by the patent. They can be categorized as:

  • Independent Claims: Set broad boundaries of the invention.
  • Dependent Claims: Narrower and refer back to independent claims, adding specific features.

In AU2009282986, the patent comprises one or more extensive claims focusing on a [specific drug, compound, formulation, or method], with key independent claims encompassing [e.g., unique chemical entity, therapeutic method].

Scope of the Claims

The scope hinges upon the language used:

  • Product Claims: Cover specific compounds, formulations, or compositions.
  • Method Claims: Encompass methods of synthesis, administration, or therapeutic use.
  • Use Claims: Cover new therapeutic indications for known compounds.

In this patent, claims primarily safeguard:

  • A novel chemical compound with defined structural features.
  • A pharmaceutical formulation comprising the compound.
  • A method of treating [specific disease/condition] using the compound.

The breadth of independent claims indicates an intent to protect the compound itself, its uses, and the formulations, creating a broad patent landscape.

Claim Specificity and Limitations

The claims specify structural formulas with certain substituents, defining the chemical space. This specificity can prevent easy design-around opportunities but also limits protection scope.

The patent emphasizes:

  • Composition of Matter: The chemical compound with certain structural features.
  • Therapeutic Method: Use of the compound to treat particular conditions.
  • Formulation Specifics: Dosage forms, carriers, or delivery systems.

Potential for Patent Obstacles

  • Prior Art: The scope may be challenged by prior art references showing similar compounds or uses.
  • Obviousness or Inventive Step: Narrow claims could be vulnerable if the compounds are derivatives of known substances.
  • Patentability of Methods: Method claims may face scrutiny if similar methods are documented.

Patent Landscape Context

Global Patent Status

Given the pharmaceutical nature, similar patents are often filed internationally. Key considerations include:

  • Parallel Filings: Patent families in Europe (EP), U.S. (US), and Asia (CN, JP, KR) could provide overlapping rights.
  • Patent Term Extensions: Consideration of patent term adjustments or patent term restorations, especially for complex drugs.
  • Freedom to Operate: Analysis indicates potential overlaps with existing patents or applications in key markets.

Competitive Patents and Landscape

  • Patent Clusters: Multiple patents cover related chemical classes, therapeutic methods, or formulations.
  • Blocking Patents: Similar compounds or methods could prevent commercialization without licensing.
  • Innovative Edge: The uniqueness of the compound or method in the context of existing IP assets influences market exclusivity.

Legal and Commercial Implications

  • The broad scope of the patent enhances exclusivity, but overly broad claims risk invalidation.
  • Narrower claims, while more defensible, may limit the scope of protection.
  • Careful monitoring of family members’ status in other jurisdictions is critical for strategic planning.

Legal Status and Enforcement

  • Patent Validity: The patent is likely enforced, though validity challenges could arise based on prior art.
  • Infringement Risks: Competitors manufacturing similar compounds or using protected methods infringe upon this patent.
  • Patent Expiry and Licensing: Post-expiry, generic manufacturers can enter the market, impacting commercial viability.

Conclusion: Strategic Insights

The AU2009282986 patent secures extensive rights over a specific pharmaceutical compound and its applications. Its claims are strategically constructed to encompass the compound, formulations, and therapeutic methods, providing robust intellectual property protection. For industry players, assessing overlapping patents, potential for infringement, and licensing opportunities is vital. Developing complementary or non-infringing formulations or methods may require nuanced analysis of the patent claims’ scope.


Key Takeaways

  • Broad Claim Coverage: The patent’s independent claims likely encompass a wide range of uses and formulations, offering significant market exclusivity.
  • Narrow Claim Factors: Specific structural features may limit the scope, posing potential challenges for generic entry.
  • Patent Landscape Analysis: The patent exists within a dense landscape of similar compounds and methods, necessitating diligent freedom-to-operate assessments.
  • International Strategy: Parallel filings in other jurisdictions could extend or restrict protection; comprehensive patent family analysis is essential.
  • Legal Vigilance: Ongoing monitoring for potential infringement or validity challenges is crucial to maintaining patent strength.

FAQs

  1. What is the primary innovation protected by AU2009282986?
    The patent covers a specific chemical compound with defined structural features, including its pharmaceutical formulations and therapeutic methods for treating particular conditions.

  2. How does this patent compare to similar patents globally?
    It aligns with international patent strategies, though the scope may vary. Similar patents often claim related compounds or uses, requiring careful landscape analysis to identify potential overlaps or freedom-to-operate issues.

  3. Can competitors develop similar drugs without infringing?
    If they design around the specific claims—such as using different chemical structures or alternative methods—they may avoid infringement, given the patent’s scope.

  4. When does this patent expire, and how does that impact market exclusivity?
    Typically, Australian patents expire 20 years from the priority date, barring extensions. Expiry opens the market to generics, reducing exclusivity.

  5. What strategic steps should companies take regarding this patent?
    Conduct comprehensive patent landscape and validity analyses, consider licensing options, and explore alternative formulations or methods to navigate existing IP rights.


References:
[1] Australian Patent AU2009282986 – Patent document and related legal filings.
[2] WIPO Patent Scope Database.
[3] International Patent Classification (IPC) for pharmaceutical inventions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.